{
  "company": "CIPLA",
  "report_date": "January 25, 2023",
  "filename": "CIPLA_transcript_Jan_2023.pdf",
  "quarter": "Q3",
  "fiscal_year": "2023",
  "management_team": [
    "MR. ASHISH ADUKIA - GLOBAL CHIEF FINANCIAL",
    "MR. UMANG VOHRA - MANAGING DIRECTOR AND",
    "MR. NAVEEN BANSAL - INVESTOR RELATIONS",
    "MR. ANKIT BHEMBRE - INVESTOR RELATIONS",
    "ASHISH ADUKIA - GLOBAL CHIEF FINANCIAL",
    "UMANG VOHRA - MANAGING DIRECTOR AND",
    "EXECUTIVE OFFICER - CIPLA LIMITED",
    "NAVEEN BANSAL - INVESTOR RELATIONS",
    "ANKIT BHEMBRE - INVESTOR RELATIONS"
  ],
  "moderator": "Ladies and gentlemen, good day, and welcome to Cipla Limited Q3 FY '23 Earnings Conference \nCall",
  "analysts": [
    {
      "name": "Saion Mukherjee",
      "firm": "Nomura Securities"
    },
    {
      "name": "Kunal Dhamesha",
      "firm": "Macquarie Group"
    },
    {
      "name": "Krishnendu Saha",
      "firm": "Quantum AMC"
    },
    {
      "name": "Prakash Agarwal",
      "firm": "Axis Capital"
    },
    {
      "name": "Shubham Goyal",
      "firm": "Motilal Oswal"
    },
    {
      "name": "Sriraam Rathi",
      "firm": "BNP Paribas"
    },
    {
      "name": "Damayanti Kerai",
      "firm": "HSBC Securities"
    },
    {
      "name": "Surya Patra",
      "firm": "PhillipCapital"
    },
    {
      "name": "Parvathi",
      "firm": "Course5i"
    },
    {
      "name": "Neha Manpuria",
      "firm": "Bank of America"
    },
    {
      "name": "Bino Pathiparampil",
      "firm": "InCred Capital"
    },
    {
      "name": "Sameer Baisiwala",
      "firm": "Morgan Stanley"
    },
    {
      "name": "Nikhil Mathur",
      "firm": "HDFC Mutual Fund"
    },
    {
      "name": "Nitin Agarwal",
      "firm": "DAM Capital"
    }
  ],
  "qa_segments": [],
  "key_financial_metrics": {
    "revenue_inr_crores": "5810",
    "sales_inr_crores": "1450",
    "growth_percentage": "6",
    "increase_percentage": "3.2"
  },
  "business_highlights": [
    "launched over 10 products, and \ntherefore, the launch momentum continued in key therapies such as cardiac, antidiabetic and \ninjectable dosage forms."
  ],
  "extraction_metadata": {
    "extraction_date": "2025-08-03T01:08:52.595029",
    "source_file": "data\\cipla\\CIPLA_transcript_Jan_2023.pdf",
    "text_length": 53624,
    "extraction_method": "PyMuPDF + Regex parsing + Filename analysis"
  }
}